Christopher Clouser is a Principal Scientist with Bristol Myers Squibb and has a background in molecular biology with a focus in Next Generation Sequencing applications development. Prior to working for Bristol Myers Squibb, he worked for Life Technologies performing methods and technology development to help launch the SOLiD and Ion Torrent sequencing platforms. In his current role, he leads a team focused on development of genomic methods to help understand CAR-T biology.